miR-221/222 promote malignant progression of glioma through activation of the Akt pathway

International Journal of Oncology

Volumn 36, Issue 4, 2010, Pages 913-920

  Zhang, Junxia ^a,b,c   Han, Lei ^b   Ge, Youlin ^a,b   Zhou, Xuan ^a,b   Zhang, Anling ^a,b   Zhang, Chunzhi ^b,d   Zhong, Yue ^a   You, Yongping ^c   Pu, Peiyu ^a,b   Kang, Chunsheng ^b,e  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Tianjin Neurological Institute   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d TIANJIN HUANHU HOSPITAL   (China)

^e Variation and Regeneration   (China)

Author keywords

Akt; Glioma; Malignant phenotype; miR 221; miR 222

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; GELATINASE A; GELATINASE B; MICRORNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOINFORMATICS; CANCER CELL CULTURE; CANCER GROWTH; CELL INVASION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; EXPERIMENTAL STUDY; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TUMOR VOLUME; WESTERN BLOTTING; XENOGRAFT;

EID: 77749340705     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000570     Document Type: Article

References (27)

1. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
2. Chen CZ: MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 353: 1768-1771, 2005.
3. Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006.
4. Yanaihara N, Caplen N, Bowman E, et al: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198, 2006.
5. Shi L, Cheng Z, Zhang J, et al: hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res 1236: 185-193, 2008.
6. Zhang C, Kang C, You Y, et al: Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo. Int J Oncol 34: 1653-1660, 2009.
7. Lu X, Zhao P, Zhang C, et al: Analysis of miR-221 and p27 expression in human gliomas. Mol Med Rep 2: 651-656, 2009.
8. Sun T, Wang Q, Balk S, Brown M, Lee GS and Kantoff P: The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines. Cancer Res 69: 3356-3363, 2009.
9. Mercatelli N, Coppola V, Bonci D, et al: The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice. PLoS One 3: e4029, 2008.
10. He H, Jazdzewski K, Li W, et al: The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102: 19075-19080, 2005.
11. Gramantieri L, Fornari F, Ferracin M, et al: MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. Clin Cancer Res 15: 5073-5081, 2009.
12. Park JK, Lee EJ, Esau C and Schmittgen TD: Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma. Pancreas (In press).
13. Medina R, Zaidi SK, Liu CG, et al: MicroRNAs 221 and 222 bypass quiescence and compromise cell survival. Cancer Res 68: 2773-2780, 2008.
14. Brummelkamp TR, Bernards R and Agami R: Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2: 243-247, 2002.
15. Kang CS, Zhang ZY, Jia ZF, et al: Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo. Cancer Gene Ther 13: 530-538, 2006.
16. You Y, Geng X, Zhao P, et al: Evaluation of combination gene therapy with PTEN and antisense hTERT for malignant glioma in vitro and xenografts. Cell Mol Life Sci 64: 621-631, 2007.
17. Le Sage C, Nagel R, Egan DA, et al: Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 26: 3699-3708, 2007.
18. Pu P, Kang C, Li J and Jiang H: Antisense and dominant-negative AKT2 cDNA inhibits glioma cell invasion. Tumour Biol 25: 172-178, 2004.
19. Zhang B, Gu F, She C, et al: Reduction of Akt2 inhibits migration and invasion of glioma cells. Int J Cancer 125: 585-595, 2009.
20. Choe G, Horvath S, Cloughesy TF, et al: Analysis of the phosphatidylinositol 3′-kinase signaling pathway in glioblastoma patients in vivo. Cancer Res 63: 2742-2746, 2003.
21. Golding SE, Morgan RN, Adams BR, Hawkins AJ, Povirk LF and Valerie K: Pro-survival AKT and ERK signaling from EGFR and mutant EGFRvIII enhances DNA double-strand break repair in human glioma cells. Cancer Biol Ther 8: 730-738, 2009.
22. Narita Y, Nagane M, Mishima K, Huang HJ, Furnari FB and Cavenee WK: Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas. Cancer Res 62: 6764-6769, 2002.
23. KIP1 expression induces anti-tumour effects and inhibits the EGFR/PI3K/Akt signalling pathway in PC3 cells. Asian J Androl (In press).
24. Kip1 reduces matrix metalloproteinase-9 and inhibits invasion of human breast cancer cells. Anticancer Res 28: 2669-2677, 2008.
25. Viglietto G, Motti ML, Bruni P, et al: Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nat Med 8: 1136-1144, 2002.
26. Dubrovska A, Kim S, Salamone RJ, et al: The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc Natl Acad Sci USA 106: 268-273, 2009.
27. Qureshi HY, Ahmad R, Sylvester J and Zafarullah M: Requirement of phosphatidylinositol 3-kinase/Akt signaling pathway for regulation of tissue inhibitor of metalloproteinases-3 gene expression by TGF-beta in human chondrocytes. Cell Signal 19: 1643-1651, 2007.